The current paradigm for biologic initiation: a confirmatory quantitative analysis of self-injection training practices
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Drug Delivery"
DOI: 10.1080/17425247.2022.2078300
Abstract: ABSTRACT Background Self-injected biologic therapies have gained significant prevalence across numerous therapeutic areas. A lack of specific guidance on best practices may lead to inadequate biologic initiation and training. We previously conducted a small-sample, qualitative… read more here.
Keywords: self injection; training; biologic initiation; injection training ... See more keywords
US Practice Patterns and Impact of Monitoring for Mucosal Inflammation After Biologic Initiation in Inflammatory Bowel Disease.
Sign Up to like & getrecommendations! Published in 2019 at "Inflammatory bowel diseases"
DOI: 10.1093/ibd/izz081
Abstract: BACKGROUND We assessed practice patterns for monitoring mucosal inflammation after biologic initiation and the association between monitoring approaches and development of disease-related complications for Crohn's disease (CD) and ulcerative colitis (UC). METHODS This study used… read more here.
Keywords: initiation; disease; monitoring mucosal; biologic initiation ... See more keywords
Delays Related to Prior Authorization in Inflammatory Bowel Disease.
Sign Up to like & getrecommendations! Published in 2022 at "Pediatrics"
DOI: 10.1542/peds.2021-052501
Abstract: BACKGROUND Delays in advancing to biologic therapies are associated with adverse outcomes in inflammatory bowel disease (IBD). Insurer-mandated prior authorizations have been linked to prolonged medication initiation times. We hypothesized that prior authorizations are associated… read more here.
Keywords: initiation time; healthcare utilization; authorization; biologic initiation ... See more keywords
Biologic initiation rates in systemic-naive psoriasis patients after first-line apremilast versus methotrexate use.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of comparative effectiveness research"
DOI: 10.2217/cer-2021-0311
Abstract: Aim: To compare rates of biologic initiation after commencing treatment with apremilast (APR) versus methotrexate (MTX) in systemic-naive patients with psoriasis (PsO). Methods: This was a retrospective cohort study of systemic-naive patients with PsO who… read more here.
Keywords: versus methotrexate; apremilast; biologic initiation; systemic naive ... See more keywords